Multibagger Shares

About Manish Goel

SEBI Registered Investment Adviser • Chartered Accountant

448 Articles Published

Manish Goel is a Chartered Accountant and the Founder of Multibagger Securities Research & Advisory Pvt. Ltd. (SEBI Registered Investment Adviser, INA100007736). A full-time value investor since 2010, he writes on value-investing principles for education and general awareness.

March 29, 2026

Hero header for article 'Loss Aversion' with subtitle; a four-block graphic showing categories: Lucky (gray), Disciplined Investor (green), Confused (light gray), Bias-Trapped (orange) against a dark blue background

Loss Aversion: Why the Pain of a Market Crash Feels 2X Worse Than the Joy of a Rally — And How to Rewire Your Investment Brain for Multibagger Returns

Nobel Prize-winning research shows losses feel 2X more painful than equivalent gains. Here's how loss aversion destroys Indian investor wealth — and how to overcome it to build multibagger returns.

March 29, 2026

ROA bar chart by fiscal year: FY20 28, FY21 26, FY22 22, FY23 18, FY24 14, FY25 11 with FY25 highlighted in green

Return on Assets (ROA): The Underrated Efficiency Metric That Reveals Whether Indian Companies Are Truly Creating Wealth — A Complete Guide for Smart Investors

📅 Published March 29, 2026 (Sunday) When most Indian investors evaluate a stock, they focus on profit margins or return on equity. But there is one […]

March 29, 2026

Hero image with headline 'The Narrative Fallacy in Stock Analysis' and a four-panel color diagram labeled Lucky, Disciplined Investor, Confused, and Bias-Trapped.

The Narrative Fallacy in Stock Analysis: Why Indian Investors Fall for Compelling Stories Instead of Hard Numbers — And How This Bias Destroys Wealth While You Think You’re Being Smart

📅 Published March 29, 2026 (Sunday) Table of Contents Toggle What Is the Narrative Fallacy — And Why Should Every Indian Investor Fear It? How the […]

March 28, 2026

Bar chart titled The Biotech Gold Rush of 2026 showing yearly values from FY20 to FY25: FY20 28, FY21 26, FY22 22, FY23 18, FY24 14, FY25 11 (green).

The Biotech Gold Rush of 2026: How Biopharma SHAKTI and AI Are Creating a Once-in-a-Generation Investment Opportunity

📅 Published March 28, 2026 (Saturday) ⚡ KEY INSIGHT The Indian biotechnology sector is experiencing a historic structural shift. Two massive developments from early 2026 have […]